Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 3, 2025 • 4:51 PM ET

Date/Time Source News Release
12/10/2024 08:30 AM EST GlobeNewswire Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial
12/03/2024 08:30 AM EST GlobeNewswire Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
11/19/2024 08:30 AM EST GlobeNewswire Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for 'Specialized BioTherapeutics Company of the Year'
11/12/2024 04:05 PM EST GlobeNewswire Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/06/2024 09:23 AM EST GlobeNewswire Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration
11/06/2024 08:30 AM EST GlobeNewswire Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024
10/31/2024 08:30 AM EDT GlobeNewswire Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events
10/28/2024 08:30 AM EDT GlobeNewswire Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis
10/03/2024 08:00 AM EDT GlobeNewswire Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor Events
09/17/2024 08:00 AM EDT GlobeNewswire Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER Trial
Page

Additional News

As of January 3, 2025 • 4:51 PM ET

Date/Time Source News Release
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Lisata Therapeutics Inc.
11/12/2024 10:07 PM EST SeekingAlpha Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript
11/12/2024 04:21 PM EST SeekingAlpha Lisata Therapeutics GAAP EPS of -$0.59 beats by $0.16
11/12/2024 02:00 PM EST InvestorBrandNetwork Dave Mazzo, CEO of Lisata Therapeutics Inc. (NASDAQ: LSTA), to Present at NobleCon20
11/08/2024 11:03 AM EST Zacks Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down
11/07/2024 10:58 AM EST Zacks Esperion's Q3 Loss Wider Than Expected, Revenues Rise Y/Y
11/07/2024 10:39 AM EST Zacks Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated
11/01/2024 12:00 PM EDT Zacks Lisata Therapeutics, Inc. (LSTA) Upgraded to Buy: Here's What You Should Know
09/05/2024 03:22 PM EDT SeekingAlpha Lisata jumps on FDA orphan drug status for liver cancer drug
08/13/2024 12:20 AM EDT SeekingAlpha Lisata Therapeutics, Inc. (LSTA) Q2 2024 Earnings Call Transcript
Page